Since lymph node metastasis is an indicator of advanced disease, our study could provide further evidence that PD-L1 might not correlate with overall patient’s prognosis but can be used as a marker for advanced disease in endometrial cancer. The gene discussed is CD274; the disease is metastatic malignant neoplasm in the lymph nodes.